浮针疗法临床适宜病种的系统整理与分析
|
摘要
系统检索中国期刊全文数据库(CNKI)、万方数据库、中国生物医学文献数据库、PubMed数据库中浮针疗法的临床研究文献,检索时限为建库至2018年1月,采用国际通用的疾病分类标准对临床文献中涉及的疾病进行分类总结,通过文献分析总结出浮针临床应用和研究中的问题对浮针专家进行咨询。结果共纳入412篇浮针疗法临床研究文献,疾病谱统计结果表明浮针被用于治疗11个系统65种疾病,其中与骨骼肌系统相关的躯体痛症为其主要临床适宜病种。符仲华教授认为浮针临床医师应选择与肌肉相关的疾病作为主要的临床研究对象,并且采用规范化的浮针操作进行治疗。其次,浮针疗法的研究尚处于初级阶段,未来需要更多高质量临床研究和基础研究对浮针疗法的疗效提供证据支持。
The clinical research articles relevant with Fu's subcutaneous needling therapy(FSN) were retrieved from CNKI, WANFANG, CBM and PubMed databases till January 2018 since the establishment of database. According to the general international criteria of disease classification, the diseases involved in the articles were classified and summarized. In terms of the clinical application and research of FSN, the questions were extracted and commented through expert's consultation. As a result, 412 articles were included. The statistical results of disease spectrum indicated that FSN was adopted in 65 kinds of diseases in 11 systems. Of these diseases, the relevant somatic pain disorders in the musculoskeletal system were the most appropriate. Professor FU Zhong-hua explained that the clinical physicians of FSN should select the muscle-related disorders as the clinical research subject and treat them with normalized manipulation of FSN. The research on FSN is still at the preliminary stage. It needs more high-quality clinical and basic researches to provide the evidences for the therapeutic effects of FSN.
The clinical research articles relevant with Fu's subcutaneous needling therapy(FSN) were retrieved from CNKI, WANFANG, CBM and PubMed databases till January 2018 since the establishment of database. According to the general international criteria of disease classification, the diseases involved in the articles were classified and summarized. In terms of the clinical application and research of FSN, the questions were extracted and commented through expert's consultation. As a result, 412 articles were included. The statistical results of disease spectrum indicated that FSN was adopted in 65 kinds of diseases in 11 systems. Of these diseases, the relevant somatic pain disorders in the musculoskeletal system were the most appropriate. Professor FU Zhong-hua explained that the clinical physicians of FSN should select the muscle-related disorders as the clinical research subject and treat them with normalized manipulation of FSN. The research on FSN is still at the preliminary stage. It needs more high-quality clinical and basic researches to provide the evidences for the therapeutic effects of FSN.
引文
[1]符仲华.浮针疗法治疗疼痛手册[M].北京:人民卫生出版社,2011.
[2]郭春艳,王苏娜,李绍荣.浮针疗法近十年的临床研究进展[J].云南中医中药杂志,2014,35(1):66-67.
[3]杨江霞,符仲华.浅析浮针的理论与临床研究[J].西部中医药,2015,28(6):156-158.
[4]朱梅芳,余航,张衍辉.浮针疗法治疗痛症的研究现状[J].江西中医药,2017,48(6):74-76.
[5]肖安菊,夏有兵,符仲华,等.浮针疗法治疗痛证研究进展[J].中国针灸,2013,33(12):1143-1146.
[6]符仲华.浮针医学纲要[M].北京:人民卫生出版社,2016.
[7]世界卫生组织.疾病和有关健康问题的国际统计分类(ICD-10)[M].北京:人民卫生出版社,2008.
[8]范刚启,符仲华,曹树平,等.浮针疗法及其对针灸学发展的启示[J].中国针灸,2005,25(10):733-736.
[9]贺青涛.浮针疗法的诊断作用体会[J].中国针灸,2015,35(S1):36-37.
[10]刘辅仁,邓云山,李伯埙,等.实用皮肤科学[M].北京:人民卫生出版社,2005:50-58.
[11]谢健周,查和萍,范志勇,等.浮针法治疗肌筋膜疼痛综合征的相关理论探讨[J].针灸临床杂志,2010,16(12):57-59.
[12]符仲华.浮针疗法的好帮手--再灌注手法[C]//2011中国针灸学会年会论文集,北京:中国针灸学会,2011:175-181.
[13]符仲华.再灌注和再灌注活动--关于外治法中边治疗边活动的方法[J].中国针灸,2015,35(S1):68-71.
[14]蒋梦姣,顾一煌.顾一煌教授基于再灌注理念治疗慢性腰肌劳损经验[J].吉林中医药,2018,38(4):458-461.
[15]刘建平.循证医学与中医疗效评价[J].中医杂志,2007,48(1):26-28.
[16]郭太品,任玉兰,李骥,等.循证针灸学及其转化应用[J].中医杂志,2014,55(12):999-1002.
[17]范小艺,王启才,陆丽娟.浮针疗法的研究进展[J].针灸临床杂志,2006,22(2):52-53.
[18]李奕萱,刘梦,张瑞杰,等.浮针治疗非疼痛性疾病临床应用举隅[J].中国针灸,2018,38(5):562-564.
[19]张宏如,符仲华,顾一煌.浮针治疗慢性咽炎31例[J].中国针灸,2013,33(3):227-228.
[20]于波.浮针治疗慢性咽炎45例[J].中医外治杂志,2007,16(5):53.
[21]葛恒璧.浮针疗法治疗阑尾炎3例[J].上海针灸杂志,2002,21(4):47.
[22]吴鲁辉,杨博华,陈蕾.系统性红斑狼疮伴雷诺综合征指端溃疡1例报道[J].中国民间疗法,2007,15(3):40.
[23]王璐,张冬梅.探析中药内服外敷加浮针围刺治疗外阴白斑的临床疗效[J].中国现代药物应用,2016,10(17):275-276.
[24]金慧洁,韩凤娟.自拟中药内服外敷加浮针围刺治疗外阴白斑20例[J].陕西中医学院学报,2014,37(4):55-56.
[25]任婉文,周志英,徐密密,等.浮针疗法与度洛西汀治疗持续的躯体形式疼痛障碍的临床研究[J].中国中西医结合杂志,2016,36(2):166-171.
[26]任婉文,徐密密,周志英,等.浮针疗法对持续性躯体形式疼痛障碍患者疼痛和生活质量的影响[J].中国现代医生,2014,52(33):58-61.
[27]陈薇,方赛男,刘建平,等.国际循证医学证据分级体系的发展与现状[J].中国中西医结合杂志,2017,37(12):1413-1419.
[28]陈耀龙,李幼平,杜亮,等.医学研究中证据分级和推荐强度的演进[J].中国循证医学杂志,2008,8(2):127-133.
[29]李桂凤,符仲华.浅谈浮针对疼痛医学发展的启示[J].中国针灸,2014,34(6):591-593.
[30]陶嘉磊,符仲华,张宏如.浮针疗法作用机制浅析[J].时珍国医国药,2014,25(12):3006-3008.
[31]范刚启,钱俐俐,赵杨,等.针刺镇痛机制的多样性及问题分析[J].中国针灸,2013,33(1):92-96.
[32]刘建平.传统医学证据体的构成及证据分级的建议[J].中国中西医结合杂志,2007,27(12):1061-1065.
[33]王吉耀,唐金陵,陈世耀.再谈循证医学[J].中国循证儿科杂志,2017,12(3):161-163.
[34]刘保延.真实世界的中医临床科研范式[J].中医杂志,2013,54(6):451-455.
[35]刘保延.中医临床疗效评价研究的现状与展望[J].中国科学基金,2010,24(5):268-274.(收稿日期:2018-05-18,编辑:张建兰)
[2]郭春艳,王苏娜,李绍荣.浮针疗法近十年的临床研究进展[J].云南中医中药杂志,2014,35(1):66-67.
[3]杨江霞,符仲华.浅析浮针的理论与临床研究[J].西部中医药,2015,28(6):156-158.
[4]朱梅芳,余航,张衍辉.浮针疗法治疗痛症的研究现状[J].江西中医药,2017,48(6):74-76.
[5]肖安菊,夏有兵,符仲华,等.浮针疗法治疗痛证研究进展[J].中国针灸,2013,33(12):1143-1146.
[6]符仲华.浮针医学纲要[M].北京:人民卫生出版社,2016.
[7]世界卫生组织.疾病和有关健康问题的国际统计分类(ICD-10)[M].北京:人民卫生出版社,2008.
[8]范刚启,符仲华,曹树平,等.浮针疗法及其对针灸学发展的启示[J].中国针灸,2005,25(10):733-736.
[9]贺青涛.浮针疗法的诊断作用体会[J].中国针灸,2015,35(S1):36-37.
[10]刘辅仁,邓云山,李伯埙,等.实用皮肤科学[M].北京:人民卫生出版社,2005:50-58.
[11]谢健周,查和萍,范志勇,等.浮针法治疗肌筋膜疼痛综合征的相关理论探讨[J].针灸临床杂志,2010,16(12):57-59.
[12]符仲华.浮针疗法的好帮手--再灌注手法[C]//2011中国针灸学会年会论文集,北京:中国针灸学会,2011:175-181.
[13]符仲华.再灌注和再灌注活动--关于外治法中边治疗边活动的方法[J].中国针灸,2015,35(S1):68-71.
[14]蒋梦姣,顾一煌.顾一煌教授基于再灌注理念治疗慢性腰肌劳损经验[J].吉林中医药,2018,38(4):458-461.
[15]刘建平.循证医学与中医疗效评价[J].中医杂志,2007,48(1):26-28.
[16]郭太品,任玉兰,李骥,等.循证针灸学及其转化应用[J].中医杂志,2014,55(12):999-1002.
[17]范小艺,王启才,陆丽娟.浮针疗法的研究进展[J].针灸临床杂志,2006,22(2):52-53.
[18]李奕萱,刘梦,张瑞杰,等.浮针治疗非疼痛性疾病临床应用举隅[J].中国针灸,2018,38(5):562-564.
[19]张宏如,符仲华,顾一煌.浮针治疗慢性咽炎31例[J].中国针灸,2013,33(3):227-228.
[20]于波.浮针治疗慢性咽炎45例[J].中医外治杂志,2007,16(5):53.
[21]葛恒璧.浮针疗法治疗阑尾炎3例[J].上海针灸杂志,2002,21(4):47.
[22]吴鲁辉,杨博华,陈蕾.系统性红斑狼疮伴雷诺综合征指端溃疡1例报道[J].中国民间疗法,2007,15(3):40.
[23]王璐,张冬梅.探析中药内服外敷加浮针围刺治疗外阴白斑的临床疗效[J].中国现代药物应用,2016,10(17):275-276.
[24]金慧洁,韩凤娟.自拟中药内服外敷加浮针围刺治疗外阴白斑20例[J].陕西中医学院学报,2014,37(4):55-56.
[25]任婉文,周志英,徐密密,等.浮针疗法与度洛西汀治疗持续的躯体形式疼痛障碍的临床研究[J].中国中西医结合杂志,2016,36(2):166-171.
[26]任婉文,徐密密,周志英,等.浮针疗法对持续性躯体形式疼痛障碍患者疼痛和生活质量的影响[J].中国现代医生,2014,52(33):58-61.
[27]陈薇,方赛男,刘建平,等.国际循证医学证据分级体系的发展与现状[J].中国中西医结合杂志,2017,37(12):1413-1419.
[28]陈耀龙,李幼平,杜亮,等.医学研究中证据分级和推荐强度的演进[J].中国循证医学杂志,2008,8(2):127-133.
[29]李桂凤,符仲华.浅谈浮针对疼痛医学发展的启示[J].中国针灸,2014,34(6):591-593.
[30]陶嘉磊,符仲华,张宏如.浮针疗法作用机制浅析[J].时珍国医国药,2014,25(12):3006-3008.
[31]范刚启,钱俐俐,赵杨,等.针刺镇痛机制的多样性及问题分析[J].中国针灸,2013,33(1):92-96.
[32]刘建平.传统医学证据体的构成及证据分级的建议[J].中国中西医结合杂志,2007,27(12):1061-1065.
[33]王吉耀,唐金陵,陈世耀.再谈循证医学[J].中国循证儿科杂志,2017,12(3):161-163.
[34]刘保延.真实世界的中医临床科研范式[J].中医杂志,2013,54(6):451-455.
[35]刘保延.中医临床疗效评价研究的现状与展望[J].中国科学基金,2010,24(5):268-274.(收稿日期:2018-05-18,编辑:张建兰)